Sullivan Richard, Paré Geneviève C, Frederiksen Lisa J, Semenza Gregg L, Graham Charles H
Department of Anatomy and Cell Biology, Queen's University, Botterell Hall, Room 859, Kingston, Ontario, Canada K7L 3N6.
Mol Cancer Ther. 2008 Jul;7(7):1961-73. doi: 10.1158/1535-7163.MCT-08-0198.
Hypoxia in solid tumors is associated with the development of chemoresistance. Although many studies have focused on the effect of hypoxia on drug-induced apoptosis, the effect of nonapoptotic pathways on hypoxia-induced drug resistance has not been previously investigated. Here, we determined the effects of hypoxia on multiple forms of drug-induced death in human MDA-MB-231 breast carcinoma cells. Clonogenic assays showed that preexposure to hypoxia leads to resistance to various classes of chemotherapeutic agents, including anthracyclines (daunorubicin and doxorubicin), epipodophyllotoxins (etoposide), and anthracenediones (mitoxantrone). Results revealed a high degree of heterogeneity in nuclear and cytoplasmic alterations in response to acute drug exposure; however, the majority of exposed cells displayed morphologic and biochemical changes consistent with drug-induced senescence. Hypoxia decreased only the proportion of cells in the senescent population, whereas the small proportion of cells exhibiting features of apoptosis or mitotic catastrophe were unaffected. Similar results were obtained with human HCT116 colon carcinoma cells, indicating that the protective effect of hypoxia on drug-induced senescence is not unique to MDA-MB-231 cells. Treatment of MDA-MB-231 cells with small interfering RNA targeting the alpha-subunit of hypoxia-inducible factor-1 (HIF-1), a key regulator of cellular adaptations to hypoxia, prevented hypoxia-induced resistance. HIF-1alpha small interfering RNA also selectively abolished the hypoxia-induced changes in the senescent population, indicating that the increased survival was due to protection against drug-induced senescence. These results support a requirement for HIF-1 in the adaptations leading to drug resistance and reveal that decreased drug-induced senescence is also an important contributor to the development of hypoxia-induced resistance.
实体瘤中的缺氧与化疗耐药性的产生有关。尽管许多研究都集中在缺氧对药物诱导的细胞凋亡的影响上,但非凋亡途径对缺氧诱导的耐药性的影响此前尚未得到研究。在此,我们确定了缺氧对人MDA-MB-231乳腺癌细胞中多种形式的药物诱导死亡的影响。克隆形成试验表明,预先暴露于缺氧环境会导致对各类化疗药物产生耐药性,包括蒽环类药物(柔红霉素和阿霉素)、表鬼臼毒素(依托泊苷)和蒽二酮(米托蒽醌)。结果显示,在急性药物暴露后,细胞核和细胞质的改变存在高度异质性;然而,大多数暴露的细胞表现出与药物诱导的衰老相一致的形态和生化变化。缺氧仅降低了衰老细胞群体中的细胞比例,而表现出凋亡或有丝分裂灾难特征的少数细胞则不受影响。在人HCT116结肠癌细胞中也获得了类似的结果,这表明缺氧对药物诱导的衰老的保护作用并非MDA-MB-231细胞所特有。用靶向缺氧诱导因子-1(HIF-1)α亚基的小干扰RNA处理MDA-MB-231细胞,HIF-1是细胞对缺氧适应的关键调节因子,可预防缺氧诱导的耐药性。HIF-1α小干扰RNA还选择性地消除了缺氧诱导的衰老细胞群体中的变化,表明存活率的提高是由于对药物诱导的衰老的保护作用。这些结果支持了HIF-1在导致耐药性的适应过程中的必要性,并揭示了药物诱导的衰老减少也是缺氧诱导的耐药性发展的一个重要因素。